Patient families and UMass Chan build a brighter future for the Duchenne community
The UMass Duchenne Program relies on philanthropic support to maintain its care model, including aid from the Hope for Gus Foundation.
Hope for Gus Mount Everest Hike Helps Raise Awareness for DMD
Jill said she’s honored to have participated in the trek. “I’m grateful to get the word out about Duchenne and to share this experience with others who we
A Trek to Everest to Raise Funds
That is the point of the Everest to End Duchenne fundraiser, said Tonya Dreher, Gus’ mother and director of Hope for Gus. The hike serves as a reminder of the difficulties faced by someone with Duchenne on a daily basis.
The Duchenne Alliance commits $500,000 to fund first Duchenne Follistatin Gene Therapy Trial
The International Duchenne Alliance announced today that it will allocate $500,000 to Jerry Mendell, M.D. and Milo Biotechnology to support the first ever follistatin gene therapy trial for DMD.
Hope for Gus collaborates with other foundations to fund Phrixus Phameceuticals
Phrixus Pharmaceuticals, Inc. today announced that it has received $67,374 in sponsored research funding from a number of DMD parent organization through the DuchenneDashboard.
Hope for Gus collaborates with other foundations to fund development of Halfuginone
Halo Therapeutics, LLC, a clinical-stage biopharmaceutical company developing novel therapeutics for rare fibrotic diseases, announced today that it has received financial support totaling $1.1 million from 12 not-for-profit foundations, including Hope For Gus.
Hope For Gus Establishes Research Grant Management System
The Duchenne Dashboard is an innovative research grant management system that will facilitate an unprecedented level of collaboration among the many foundations, patient advocacy groups, and scientists dedicated to finding treatments and cures for Duchenne.